Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Adrenocortical Carcinoma × Sunitinib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Renal Cell 145 Kidney Neoplasms 42 Neoplasms 39 Neoplasm Metastasis 35 Breast Neoplasms 33 Gastrointestinal Stromal Tumors 31 Carcinoma, Non-Small-Cell Lung 22 Prostatic Neoplasms 16 Urinary Bladder Neoplasms 13 Colorectal Neoplasms 12 Brain Neoplasms 12 Pancreatic Neoplasms 11 Glioblastoma 11 Carcinoma, Hepatocellular 11 Melanoma 10 Lung Neoplasms 10 Carcinoma 10 Stomach Neoplasms 8 Neuroendocrine Tumors 8 Thyroid Neoplasms 7 Sarcoma 7 Ovarian Neoplasms 7 Multiple Myeloma 7 Liver Neoplasms 7 Adenoma, Islet Cell 7 Small Cell Lung Carcinoma 6 Leukemia, Myeloid, Acute 6 Glioma 6 Esophageal Neoplasms 6 Clear-cell metastatic renal cell carcinoma 6

Interventions

Mitotane 10 Cisplatin 9 pembrolizumab 7 Doxorubicin 6 Etoposide 5 Specimen Handling 4 Nivolumab 4 Magnetic Resonance Spectroscopy 4 relacorilant 3 cabozantinib 3 Cytoreduction Surgical Procedures 3 sodium thiosulfate 2 cixutumumab 2 cemiplimab 2 camrelizumab 2 apatinib 2 Trastuzumab 2 Suramin 2 Radiotherapy 2 Ipilimumab 2 Dichlorodiphenyldichloroethane 2 Cyclophosphamide 2 tipifarnib 1 pegfilgrastim 1 milademetan 1 lenvatinib 1 iodophenyl metomidate 1 gossypol acetic acid 1 fludarabine phosphate 1 entinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00453895 2019-01-31

SIRAC

University of Wuerzburg

Phase 2 Completed

39 enrolled 10 charts

Adrenocortical Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡